Swiss National Bank Takes Position in Genpact Limited (NYSE:G)

Swiss National Bank bought a new position in Genpact Limited (NYSE:G) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 332,900 shares of the business services provider’s stock, valued at approximately $14,298,000. Swiss National Bank owned about 0.19% of Genpact as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of G. Victory Capital Management Inc. increased its stake in Genpact by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider’s stock worth $423,205,000 after acquiring an additional 1,511,790 shares during the last quarter. Franklin Resources Inc. raised its holdings in Genpact by 6.5% in the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock valued at $162,318,000 after buying an additional 252,674 shares during the period. Geode Capital Management LLC raised its holdings in Genpact by 12.6% in the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock valued at $148,142,000 after buying an additional 413,646 shares during the period. JPMorgan Chase & Co. lifted its position in Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after buying an additional 2,060,595 shares in the last quarter. Finally, Tandem Investment Advisors Inc. grew its stake in Genpact by 390.5% during the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider’s stock worth $91,480,000 after buying an additional 1,695,706 shares during the period. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

G has been the topic of several recent research reports. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and lifted their target price for the company from $45.00 to $60.00 in a report on Friday, February 7th. Needham & Company LLC boosted their price objective on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and increased their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, Mizuho boosted their price target on Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $48.44.

Insider Buying and Selling at Genpact

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by insiders.

Genpact Stock Performance

Genpact stock opened at $51.17 on Thursday. The stock has a market cap of $8.99 billion, a P/E ratio of 18.02, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average of $50.01 and a 200-day moving average of $44.51. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76.

Genpact (NYSE:G) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be issued a $0.17 dividend. This is a positive change from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s payout ratio is currently 23.94%.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.